|
|
 |
TB in the USA: Worse Than We Thought?
This model demonstrated that because there is a high level of resistance to isoniazid, three months of rifampin should be considered for children with latent TB infections, assuming that the child originates from a country where 11% (or more) of TB is isoniazid-resistant. Our current policy of isoniazid is both more costly and less effective. . . .
keep reading
|
DOTS for TB
A short course of medications to treat active tuberculosis when administered under direct supervision is a cost-effective strategy (World Health Organization [1993]). The Centers for Disease Control and Prevention (CDC) established guidelines for directly-observed treatment which promotes treatment adherence and completion and reduces the risk of drug-resistant infection. . . .
keep reading
|
|
|
|
|
